Literature DB >> 31562839

Longitudinal Outcomes After Surgical Repair of Postinfarction Ventricular Septal Defect in the Medicare Population.

George J Arnaoutakis1, Arman Kilic2, John V Conte3, Sunghee Kim4, J Matthew Brennan5, Brian C Gulack5, Fred H Edwards6, Jeffrey P Jacobs7, Ibrahim Sultan8.   

Abstract

BACKGROUND: Patients undergoing post infarction ventricular septal defect repair are at high risk for early morbidity and mortality, but little is known about subsequent clinical events. This study uses short-term clinical data from The Society of Thoracic Surgeons National Database linked with Medicare data to examine longer term outcomes in these patients.
METHODS: This was a retrospective review of The Society of Thoracic Surgeons National Database to link with Medicare data all adults (≥65 years) who underwent ventricular septal defect repair after a myocardial infarction between 2008 and 2012. The primary outcome was 1-year mortality. Risk factors for 1-year survival were modeled using a multivariable Cox regression.
RESULTS: Five hundred thirty-seven patients were identified using The Society of Thoracic Surgeons database and Medicare linkage. Median age was 74 years, and 277 patients (52%) were men. One hundred ninety-two patients (36%) were supported preoperatively with an intraaortic balloon pump. Surgical status was emergent or salvage in 138 (26%), and 158 patients (29%) died within 30 days and 207 (39%) within 1 year. Among patients who survived to hospital discharge, 44% were discharged to a facility and 172 (32%) experienced at least 1 all-cause readmission within 1 year. Unadjusted 1-year mortality rates were 13% for elective patients and 69% for emergency status (P < .01). On multivariable analysis emergency/salvage status, older age, and concomitant coronary artery bypass grafting were independently associated with worse 1-year survival.
CONCLUSIONS: These data suggest the greatest mortality risk in this patient population occurs in the first 30 days. Emergency or salvage status strongly predicts 1-year mortality. Optimizing physiologic derangements before operative repair may be considered when possible in this subgroup of patients.
Copyright © 2020 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31562839     DOI: 10.1016/j.athoracsur.2019.08.024

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  Surgical management for mechanical complications of acute myocardial infarction: a systematic review of long-term outcomes.

Authors:  Sarah Yousef; Ibrahim Sultan; Helena M VonVille; Kevin Kahru; George J Arnaoutakis
Journal:  Ann Cardiothorac Surg       Date:  2022-05

2.  One-year outcome and survival analysis of deferred ventricular septal repair in cardiogenic shock supported with mechanical circulatory support.

Authors:  Jahanzeb Malik; Faizan Younus; Asmara Malik; Muhammad Umar Farooq; Ahmed Kamal; Muhammad Shoaib; Hesham Naeem; Ghazanfar Rana; Abdul Sattar Rana; Muhammad Usman; Shahid Khalil
Journal:  PLoS One       Date:  2021-08-18       Impact factor: 3.752

3.  Concomitant surgical revascularization in postinfarction ventricular septal rupture and ventricular aneurysm repair: A straightforward indication or a prognostic factor?

Authors:  Daniele Ronco; Matteo Matteucci; Giulio Massimi; Roberto Lorusso
Journal:  J Card Surg       Date:  2022-06-15       Impact factor: 1.778

Review 4.  Mechanical Complications of Acute Myocardial Infarction: A Scientific Statement From the American Heart Association.

Authors:  Abdulla A Damluji; Sean van Diepen; Jason N Katz; Venu Menon; Jacqueline E Tamis-Holland; Marie Bakitas; Mauricio G Cohen; Leora B Balsam; Joanna Chikwe
Journal:  Circulation       Date:  2021-06-15       Impact factor: 39.918

5.  Emergency sandwich patch repair via right ventricular incision for postinfarction ventricular septal defects: a case series.

Authors:  Yusuke Shimahara; Satsuki Fukushima; Shin Yajima; Naoki Tadokoro; Takashi Kakuta; Yasuhide Asaumi; Junjiro Kobayashi; Tomoyuki Fujita
Journal:  Eur Heart J Case Rep       Date:  2021-05-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.